Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-14-063557

Director acquired 44,075.48 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Gunton James T. Director 2014-10-09 Conversion +44,075.48 121,755,472 I
Derivatives
Gunton James T. Director 2014-10-09 Conversion · Series B 10% Convertible Preferred Stock −44,075.48 0 I
Loading xslF345X03/v392329_4.xml…